1INSERM UMR 1163, Laboratory of Molecular and pathophysiological bases of cognitive disorders, Imagine Institute, Necker-Enfants Malades Hospital, 24 Boulevard du Montparnasse, 75015 Paris, France.
Paris Descartes-Sorbonne Paris Cité University, 12 Rue de l'École de Médecine, 75006 Paris, France.
Mol Autism. 2018 Jun 19;9:38. doi: 10.1186/s13229-018-0219-3. eCollection 2018.
MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression at the post-transcriptional level. miRNAs have emerged as important modulators of brain development and neuronal function and are implicated in several neurological diseases. Previous studies found upregulation is the most common miRNA deregulation event in neurodevelopmental disorders such as autism spectrum disorder (ASD), epilepsy, and intellectual disability (ID). Yet, how upregulation affects the developing fetal brain remains unclear.
We analyzed the expression of in the temporal lobe of ASD children using Taqman assay. To assess the role of in early brain development, we generated and characterized stably induced H9 human neural stem cell (H9 hNSC) overexpressing using various cell and molecular biology techniques.
We first showed that upregulation occurs early during childhood in the ASD brain. In H9 hNSC, overexpression enhances neurite outgrowth and branching and favors differentiation into neuronal like cells. Expression analyses revealed that 10% of the transcriptome was deregulated and organized into two modules critical for cell cycle control and neuronal differentiation. Twenty known or predicted targets of were significantly deregulated in the modules, acting as potential drivers. The two modules also display distinct transcription profiles during human brain development, affecting regions relevant for ASD including the neocortex, amygdala, and hippocampus. Cell type analyses indicate markers for pyramidal, and interneurons are highly enriched in the deregulated gene list. Up to 40% of known markers of newly defined neuronal lineages were deregulated, suggesting that could participate also in the acquisition of neuronal identities.
Our results demonstrate the dynamic roles of in early neuronal development and provide new insight into the molecular events that link overexpression to impaired neurodevelopment. This, in turn, may yield new therapeutic targets and strategies.
微小 RNA(miRNA)是一种小的非编码 RNA,可在转录后水平调节基因表达。miRNA 已成为大脑发育和神经元功能的重要调节因子,并与几种神经疾病有关。先前的研究发现,上调是自闭症谱系障碍(ASD)、癫痫和智力障碍(ID)等神经发育障碍中最常见的 miRNA 失调事件。然而,上调如何影响发育中的胎儿大脑尚不清楚。
我们使用 Taqman 测定法分析了 ASD 儿童颞叶中 的表达。为了评估 在早期大脑发育中的作用,我们使用各种细胞和分子生物学技术生成并表征了稳定诱导过表达 的 H9 人神经干细胞(H9 hNSC)。
我们首先表明,在 ASD 大脑中,上调发生在儿童早期。在 H9 hNSC 中,过表达增强了神经突的生长和分支,并有利于向神经元样细胞分化。表达分析显示,转录组的 10%被失调,并组织成两个对细胞周期控制和神经元分化至关重要的模块。 的 20 个已知或预测靶标在模块中显著失调,作为潜在的驱动因素。这两个模块在人类大脑发育过程中也显示出不同的转录谱,影响与 ASD 相关的区域,包括大脑皮层、杏仁核和海马体。细胞类型分析表明,锥体细胞和中间神经元的标志物在失调基因列表中高度富集。多达 40%的新定义神经元谱系的已知标志物被失调,表明 也可能参与获得神经元身份。
我们的研究结果证明了 在早期神经元发育中的动态作用,并为将 上调与神经发育障碍联系起来的分子事件提供了新的见解。这反过来又可能为新的治疗靶点和策略提供依据。